Research & Development: Page 46
-
PharmaVoice Team/PharmaVoice
Solutions for Clinical Sites
Clinical study sites are transforming their technology infrastructures with the adoption of electronic medical records (EMRs). But while EMRs improve treatment-related tasks in healthcare settings, they have not helped to reduce the burden of clinical trial studies on the sites. A May 2017 survey...
By Denise Myshko • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
Upfront
Bayer and the White Ribbon Alliance The partnership of Bayer and the White Ribbon Alliance (WRA), Every Woman Every Child, has reached 1,200 women in 91 communities across four developing countries. The partnership’s goal has been to launch local community programs to support the reduction and pr...
By PharmaVoice Team • Sept. 1, 2017 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
HealthTech
New Exhaled Breath Sensor Spots Diseases, Monitors Health Trend Watch: The application of very small things to yield very big health results A study published in the Accounts of Chemical Research journal reports that Korea Advanced Institute of Science and Technology’s researchers have developed ...
By PharmaVoice Team • Sept. 1, 2017 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A New Option for PAH Preston Klassen, M.D., Executive VP, Research and Development and Chief Medical Officer, Arena Pharmaceuticals, talks about the company’s efforts to develop a new therapy for pulmonary hypertension. Pulmonary arterial hypertension (PAH) is a rare disease that affects the hear...
By Preston Klassen • Sept. 1, 2017 -
PharmaVoice Team/PharmaVoice
Speak Out
TREATING THE WHOLE PATIENT: A More Compelling Approach to Product Development Instead of focusing only on your product, consider the impact if your product was studied in tandem with an intervention that addresses whole patient needs. By taking this approach, you’re formulating a plan to differen...
By Mark Matthews • Sept. 1, 2017 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Storied Careers This is my favorite issue of the year — nothing against the other great issues we put out every month. But there is something particularly special about showcasing 100 men and women who have dedicated their lives to the life-sciences industry. They could be using their talents in ...
By Taren Grom • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. Change Agents Danielle Bedard inVentiv Health Kathy Biberstein Alkermes Kim Carpenter HCB Health Dr. Ryan Cohlhepp Takeda Oncology Su...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Clinical Experts
Mark Penniston The Curious Pragmatist Title: Executive VP and General Manager, Clinical Analytics & Source Company: Chiltern Education: BS, MS, University of Massachusetts Family: Wife, Melissa Hobbies: Reading, traveling to National Parks & Disney Social Media: In this biotech environmen...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Innovators
Dr. Bill Byrom At the Forefront of eClinical Technology Title: Senior Director of Product Innovation Company: ICON Clinical Research Education: BSc, Mathematics with Statistics, University of Nottingham; PhD, University of Strathclyde Family: Wife, Tina; two teenage daughters, Charlotte and Sophi...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Patient Advocates
Nikki Levy Caring Connections Title: VP, Patient Engagement Company: Alkermes Inc. Education: BS, Communications, Illinois State University Family: As a child of a single mom she learned to be fiercely independent, internally motivated and to value hard work Hobbies: Running, reading, traveling A...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Dr. Daniel Auclair Bridging the Cancer Gaps Title: Senior VP, Research Company: Multiple Myeloma Research Foundation Education: BS, Biochemistry, MSc, Biochemistry, University of Montreal; PhD, Nutrition/Biochemistry, Dana-Farber Cancer Institute/Harvard Cancer Center Family: Father — lost to an ...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Technologists
Steve Powell Tackling Technology Innovation with a Patient-Focus Title: Executive VP of Trial Oversight Company: ERT Education: BSc (Hons), Mathematics, University of Wales, Cardiff Family: Lori, his wife who supports him in the career decisions and the changes he makes; Betty and Eddie, his mot...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
Red Jacket Awards
2017 Red Jacket Honorees PharmaVOICE introduced the Red Jacket Award in 2014 to celebrate the 10th anniversary of the PharmaVOICE 100. One of the criteria for being named a Red Jacket — our version of a Hall of Fame — is having been recognized previously as a PharmaVOICE 100 honoree, but it’s muc...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Regenerative Medicine Research Tackles Hearing Loss Chris Loose, Ph.D., Co-founder and Chief Scientific Officer at Frequency Therapeutics, talks about his company’s efforts to develop a small molecule therapy to restore hearing. Hearing loss is usually the result of inner ear or nerve damage. Agi...
By Chris Loose • June 1, 2017 -
PharmaVoice Team/PharmaVoice
HealthTech
J&J Company Buys 3D Printing Technology to Create Bone-healing Implants Trend Watch: Pharma, academia, and health techs employ innovation to improve patient care. DePuy Synthes Products, part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Reg...
By PharmaVoice Team • June 1, 2017 -
PharmaVoice Team/PharmaVoice
The Clinical Trials Technology Ecosystem
Data are — and will continue to be — the linchpin for clinical trials. In the future, fewer data points will come from the traditional investigator-led EDC data entry process. Emerging technologies offer an incredible potential in transforming drug development. The ability to pool real-world data...
By PharmaVoice Team • June 1, 2017 -
PharmaVoice Team/PharmaVoice
City Centers of Excellence
There is no disputing that the top two centers of R&D excellence in the country are San Francisco and Cambridge, Mass. However, there is much friendly debate between the two locations on which hub actually takes first place. While Bloomberg Business recently ranked Massachusetts No. 1 for inn...
By Robin Robinson • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Malaria Research Update
Despite the successful deployment of multiple interventions against malaria, there were an estimated 212 million cases of malaria and an estimated 429,000 malaria deaths worldwide in 2015, according to the most recent figures from the World Health Organization. Malaria is a mosquito-borne disease...
By Denise Myshko • June 1, 2017 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Clinical Trial Solutions: Redefining the Clinical Trial Solution Landscape
Clinical trial solutions bring together technology, product, and services to automate and better manage the clinical trial process. In addition to helping to reduce time and cost, clinical trial solutions are also vital for improving data management and in integrating data from different trials f...
By PharmaVoice Team • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Moving Down the Digital Path: The Next Evolution in Clinical Trials Testing
The continued emergence of personalized medicine alongside the need for more consistent and less variable tissue analysis and interpretation has led to an increased reliance on central laboratories to perform anatomic pathology testing and services in support of clinical studies. This demand, cou...
By Robert A. Carlson • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Responding to Increased FDA Focus on Data Integrity
As clinical trials grow in complexity and new technologies emerge for capturing clinical data, the need to improve sustainability of data integrity throughout study conduct has heightened. Over the past five years, the volume of data integrity-related CGMP violations have grown in prevalence. In ...
By Don Zinn • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Can CRA Empowerment Make Clinical Trials More Successful?
A high clinical research associate (CRA) turnover rate — exceeding 25% annually — coupled with an often checklist-driven monitoring style can lead to a toxic environment for site staff. This impersonal atmosphere can lead to a negative feedback loop, in which CRAs become disengaged with the job a...
By John Boland • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Choosing the Right EDC/DM Partner: Critical Considerations for Small-toMedium-Sized Life Sciences Organizations
Whether you are a start-up pharmaceutical or biotech company, a medical devices innovator, or an established organization you want to be equipped with the best possible solution for your study. For small- to medium-sized organizations finding an eClinical partner that is not only competitive but ...
By Andrew Schachter • June 1, 2017 -
PharmaVoice Team/PharmaVoice
21st Century Trials Demand 21st Century Technology
The pharmaceutical industry can pride itself on its use of state-of-the art technology in drug discovery using such advances as robotics, molecular modeling, and powerful computational software. Oddly, though, the industry has been slow to take advantage of technology to support clinical operatio...
By Chris Hall • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Transforming Trials: Reducing Cost and Risk
The total sponsor cost per new drug compound approved in the United States now exceeds $2.5 billion, including nearly $1.5 billion for clinical development — an astounding 145% jump in just 15 years, according to the Tufts Center for the Study of Drug Development1. With just 7% of first-in-human ...
By Dr. Phil Birch • June 1, 2017
Previous
